Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2; this appears to be a metadata update without substantive changes to study details.SummaryDifference0.1%

- Check28 days agoChange DetectedThe NIH funding operating status notice was removed from the page, with no impact on the core study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedNo significant changes detected between the two screenshots; the page content, including the title and key study details, appears unchanged.SummaryDifference0.5%

- Check71 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference3%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion bump to v3.0.2 from v3.0.1; no core content or data changes detected. The removal of 'Back to Top' is a minor UI adjustment.SummaryDifference0.2%

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.